Isospec and Agilent Announce Collaboration on Molecular Identification

Lausanne, December 4, 2024 - Isospec Analytics, a pioneer in cryogenic spectroscopy for molecular identification, and Agilent Technologies, a global leader in life sciences and diagnostics, announced today a collaboration aimed at revolutionizing biomolecular analysis.

Revolutionizing Molecular Identification

This collaboration aims to usher in a paradigm shift in molecular identification by bringing together Isospec's cutting-edge technology with Agilent's renowned high-resolution mass spectrometry (MS) and liquid chromatography (LC) capabilities. The direct integration of cryogenic infrared spectroscopy within an LC/MS instrument provides a new orthogonal data dimension that leverages the exceptional sensitivity of MS with the exquisite structural elucidation capabilities of cryogenic IR spectroscopy. This hybrid technology will revolutionize glycomics and metabolomics, enabling breakthroughs in nutrition, disease diagnostics and personalized health.

Synergizing Expertise

Isospec contributes its extensive experience and innovation in combining cryogenic spectroscopy with mass spectrometry, which opens unprecedented molecular identification capabilities.

Agilent brings to the table its world-class engineering prowess, efficient manufacturing processes, extensive distribution channels, and a vast clientele built on a reputation for producing high-quality scientific instruments. Their global presence and marketing capabilities will ensure that this groundbreaking technology reaches researchers across the globe, accelerating breakthroughs in pharmaceuticals, biotechnology, and academic research.

‍

Dr. Ahmed Ben Faleh, CEO of Isospec commented, "This collaboration with Agilent marks a significant milestone in our mission to advance molecular identification techniques. We're excited at the prospect of seeing our technology reach a wider audience and contribute to groundbreaking research worldwide."

‍

Dr. Shane Tichy, Associate Vice President of Research and Development at Agilent, added, “Isospec and Agilent are aligned in their commitment to innovation and excellence. By integrating Isospec’s cryogenic IR spectroscopy with  Agilent’s 6546 LC/QTOF instrument, we will  provide our customers with enhanced analytical capabilities and new insights into complex chemical analyses.”

‍

For more information about this collaboration and updates on the technology development, please visit www.isospec.bio or contact info@isospec.bio

About Isospec

Isospec Analytics SA is a Swiss start-up spun off from the laboratory of Prof. Thomas Rizzo at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in 2022. Based on the long experience of the Rizzo Lab in combining mass spectrometry and cryogenic ion spectroscopy, Isospec is focused on developing powerful new bioanalytical tools for the life sciences.

‍